BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2579018)

  • 1. S-100 protein immunostaining in the differential diagnosis of chondroblastoma.
    Monda L; Wick MR
    Hum Pathol; 1985 Mar; 16(3):287-93. PubMed ID: 2579018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type II collagen, but not aggrecan expression, distinguishes clear cell chondrosarcoma and chondroblastoma.
    Söder S; Oliveira AM; Inwards CY; Müller S; Aigner T
    Pathology; 2006 Feb; 38(1):35-8. PubMed ID: 16484006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chondroblastoma and clear cell chondrosarcoma: radiological and MRI characteristics with histopathological correlation.
    Kaim AH; Hügli R; Bonél HM; Jundt G
    Skeletal Radiol; 2002 Feb; 31(2):88-95. PubMed ID: 11828329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation and proliferative activity in benign and malignant cartilage tumors of bone.
    Hasegawa T; Seki K; Yang P; Hirose T; Hizawa K; Wada T; Wakabayashi J
    Hum Pathol; 1995 Aug; 26(8):838-45. PubMed ID: 7543439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical distribution of S-100 protein in tumors and tumor-like lesions of bone and cartilage.
    Okajima K; Honda I; Kitagawa T
    Cancer; 1988 Feb; 61(4):792-9. PubMed ID: 3276387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopathological analysis, immunohistochemical study and electron microscopic observation of chondroblastoma of bone].
    Wang LT
    Zhonghua Wai Ke Za Zhi; 1993 Dec; 31(12):717-21. PubMed ID: 8033700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers aiding the diagnosis of chondroid tumors: an immunohistochemical study including osteonectin, bcl-2, cox-2, actin, calponin, D2-40 (podoplanin), mdm-2, CD117 (c-kit), and YKL-40.
    Daugaard S; Christensen LH; Høgdall E
    APMIS; 2009 Jul; 117(7):518-25. PubMed ID: 19594492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H3F3 mutation status of giant cell tumors of the bone, chondroblastomas and their mimics: a combined high resolution melting and pyrosequencing approach.
    Kervarrec T; Collin C; Larousserie F; Bouvier C; Aubert S; Gomez-Brouchet A; Marie B; Miquelestorena-Standley E; Le Nail LR; Avril P; Christophe Pagès J; de Pinieux G
    Mod Pathol; 2017 Mar; 30(3):393-406. PubMed ID: 28059095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovered on gastrointestinal stromal tumour 1 (DOG1): a useful immunohistochemical marker for diagnosing chondroblastoma.
    Akpalo H; Lange C; Zustin J
    Histopathology; 2012 Jun; 60(7):1099-106. PubMed ID: 22335248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Giant cell reparative granuloma and other giant cell lesions of the bones of the hands and feet.
    Picci P; Baldini N; Sudanese A; Boriani S; Campanacci M
    Skeletal Radiol; 1986; 15(6):415-21. PubMed ID: 3764467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S-100 protein in tumors of cartilage and bone. An immunohistochemical study.
    Nakamura Y; Becker LE; Marks A
    Cancer; 1983 Nov; 52(10):1820-4. PubMed ID: 6354416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of 36 cases of chondroblastomas: A single institutional experience.
    Rekhi B; Ghate S; Shah A; Ramadwar M; Gulia A
    Ann Diagn Pathol; 2020 Feb; 44():151440. PubMed ID: 31862519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrastructure of cartilaginous tumors and S-100 protein in the tumors. With reference to the histogenesis of chondroblastoma, chondromyxoid fibroma and mesenchymal chondrosarcoma.
    Ushigome S; Takakuwa T; Shinagawa T; Takagi M; Kishimoto H; Mori N
    Acta Pathol Jpn; 1984 Nov; 34(6):1285-300. PubMed ID: 6524378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of immunohistochemical expression of H3.3K36M and DOG1 in the diagnosis of chondroblastomas: An experience from a tertiary cancer referral center.
    Rekhi B; Dave V; Butle A; Dutt A
    Ann Diagn Pathol; 2023 Oct; 66():152174. PubMed ID: 37356274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chondroblastoma: An Update.
    Chen W; DiFrancesco LM
    Arch Pathol Lab Med; 2017 Jun; 141(6):867-871. PubMed ID: 28557595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P63 expression as a biomarker discriminating giant cell tumor of bone from other giant cell-rich bone lesions.
    Shooshtarizadeh T; Rahimi M; Movahedinia S
    Pathol Res Pract; 2016 Oct; 212(10):876-879. PubMed ID: 27473669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clear Cell Chondrosarcoma With Chondroblastoma-Like Features: A Case for Team Diagnosis.
    Kiefer RM; Wojcik J; Cooper K; Weber KL; Sebro R
    Int J Surg Pathol; 2018 Dec; 26(8):766-771. PubMed ID: 29774790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cartilaginous tumors of the skeleton].
    Meffert O; Peiper HJ
    Chirurg; 1976 Jul; 47(7):392-9. PubMed ID: 954515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The H3F3 K36M mutant antibody is a sensitive and specific marker for the diagnosis of chondroblastoma.
    Amary MF; Berisha F; Mozela R; Gibbons R; Guttridge A; O'Donnell P; Baumhoer D; Tirabosco R; Flanagan AM
    Histopathology; 2016 Jul; 69(1):121-7. PubMed ID: 26844533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chondroblastoma and its differential diagnosis].
    Forest M; De Pinieux G
    Ann Pathol; 2001 Dec; 21(6):468-78. PubMed ID: 11910934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.